Humana reported 2025 revenue of $129.66 billion and Q1 2026 revenue of $39.65 billion. The thesis turns on whether Medicare Advantage scale can translate into durable margins and cash flow while medical cost trends, rate pressure and regulatory scrutiny remain central risks.